NanoVibronix shareholders approve reverse stock split with 1:2 to 1:50 range

ENvue Medical, Inc.

Reverse stock split amendment approved: ratio of 1-for-2 to 1-for-50, at Board discretion, within one year.
Votes: 550,179 for, 183,224 against, 33,836 abstentions.
Adjournment proposal approved (573,509 for, 166,066 against) but not needed.
Special meeting held July 17, 2025; previously adjourned from July 11.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.